Firefly Bio announced it raised $40 Million in an initial filing from an offering of $72 Million

Mar 26, 2024•over 1 year ago

Amount Raised

$40 Million

San FranciscoBiotechnologyHealth Care

Company Information

Company

Firefly Bio

Location

San Francisco, California, United States

About

Firefly Bio is a biotech company focused on developing a novel platform to treat cancer using degrader antibody conjugates (DACs). The company aims to precisely drug a range of intracellular biological targets that were previously hampered by therapeutic index issues when delivered systemically.

Related People

2 contacts

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Firefly Bio announced it raised $40 Million in an initial filing from an offering of $72 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information